With Scientific, Operational, and Commercial Acumen GBC Offers Practical Solutions to Turn Expertise and Innovation into Success Neil R. Mucci CEO - GBC Informed, Fast, and Adaptive Approaches to Clinical Research Studies Clinical Trial Management, Quality System Management, and Monitoring Services Biospecimen Acquisition and Biorepository Expertise Committed to Shortening Research and Development Timelines and Maximizing Client Value Accelerating the Promise of Predictive, Prognostic, Personalized, and Participatory Medicine Global BioClinical In Vitro Diagnostic Clinical Trial Services Consulting Business Clinical Trials Biospecimens NEWS Teal Health Unveils Landmark Study Results Showing Teal Wand™ Self-Collected Samples Match Clinician Collected SamplesGBC Partners with Boudicca DX to Become a One Stop Global Shop for Strategy and Execution for Medical Device & In Vitro Diagnostic CompaniesMUSE Microscopy Showcasing SmartPath MUSE TechnologyTeal Health Completes Clinical Trial at Record Speed and Receives FDA Breakthrough Designation for Its At-Home Cervical Cancer Screening Device, the Teal Wand™ GBC BLOG Mainz Biomed Enrolls First Patient in Its eAArly DETECT 2 Clinical StudyGuardant Health’s Shield Colorectal Cancer Blood Test Garners CMS Advanced Diagnostic StatusFood and Drug Administration Announces the Availability of New Draft Guidance for Industry: “E6(R3) Guideline for Good Clinical Practic.”January is Cervical Cancer Awareness Month
